tradmap

CLDX Celldex Therapeutics, Inc.

$39.35 -0.32%

Updated

Healthcare · In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc. (CLDX) is a healthcare company in the In Vitro & In Vivo Diagnostic Substances industry, with a market capitalization of $3.1 billion. Shares last traded at $39.35, 12.9% below their 52-week high. Over the past year the stock is up 66.4%. Revenue declined 78.0% year over year.

Market Cap
$3.1B
Shares Out
78.5M
EPS (TTM)
$-7.62
P/E Ratio
P/S Ratio
2000.34
P/B Ratio
4.33
Dividend / Share
Dividend Yield
52-Week High
$45.19
52-Week Low
$19.00
Volume
18,838
Avg Vol (3m)
54,306.683

Performance

1W
-2.61%
1M
-4.06%
3M
+31.45%
6M
+34.04%
YTD
+45.79%
1Y
+66.44%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
47.35
SMA (50)
$38.83
SMA (200)
$31.47
Price vs SMA50
+1.34%
Price vs SMA200
+25.04%
ATR (14)
$2.07

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2M
Net Income
$-301M
Gross Margin
Operating Margin
Net Margin
Return on Equity
-42.1%
Return on Assets
-38.4%
Current Ratio
11.82
Debt / Equity
0.09
Revenue Growth (YoY)
-78.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-2.11 2026-08-06
Q1 2026 $-1.18 2026-05-07
FY 2025 $-3.90 2026-02-25
Q3 2025 $-2.67 2025-11-10
Q2 2026 $-1.66 2026-08-06
Q1 2026 $-0.81 2026-05-07

Full earnings history →

In Vitro & In Vivo Diagnostic Substances peers

CLDX vs 14 industry peers (In Vitro & In Vivo Diagnostic Substances), by market cap. Updated

P/S vs peers
2000.34 / 4.24 med
+47132% premium
1–14 of 14
IDXXIdexx Laboratories$41.7B36.589.1625.0%-1.81%
LNTHLantheus Holdings, Inc.$6.6B23.944.2417.7%+0.17%
CLDXCelldex Therapeutics, Inc.$3.1B-10.282000.34-0.32%
NEOGNeogen Corp$2.5B-322.002.92-0.9%-1.36%
NTLAIntellia Therapeutics, Inc.$1.8B-4.44-0.63%
QDELQuidelortho Corp$955M-0.910.36-39.2%-0.11%
ACHVAchieve Life Sciences, Inc.$855M-7.49-2.18%
TKNOAlpha Teknova, Inc.$388M-23.128.87-38.4%-2.83%
MYGNMyriad Genetics Inc$309M-2.740.38-14.0%-0.31%
IMDXInsight Molecular Diagnostics Inc.$135M-2.7433.41+2.99%
ICCCIMMUCELL CORP /DE/$90M114.192.932.6%-0.35%
QCLSQ/C TECHNOLOGIES, INC.$15M-0.939.79-1.57%
BMRABIOMERICA INC$10M-2.732.31-84.8%+2.51%
CDIOCardio Diagnostics Holdings, Inc.$5M-0.84374.80-1.08%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.